Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease

Cell Death and Disease

Volumn 1, Issue 1, 2010, Pages

  Yacoubian, T A ^a   Slone, S R ^a   Harrington, A J ^b   Hamamichi, S ^b   Schieltz, J M ^b   Caldwell, K A ^a,b   Caldwell, G A ^a,b   Standaert, D G ^a  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

synuclein; 14 3 3; MPP+; Parkinsons disease; rotenone; transgenic

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; DIFOPEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 THETA; PROTEIN INHIBITOR; ROTENONE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ISOPROTEIN; PROTEIN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CELL LINE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG RESISTANCE; GLIOMA CELL; HUMAN; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALIA; CAENORHABDITIS ELEGANS;

1-METHYL-4-PHENYLPYRIDINIUM; 14-3-3 PROTEINS; ALPHA-SYNUCLEIN; ANIMALS; CAENORHABDITIS ELEGANS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; PARKINSON DISEASE; PROTEIN ISOFORMS; PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; ROTENONE;

EID: 77952216305     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2009.4     Document Type: Article

References (40)

1. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386. (Pubitemid 46184217)
2. Athanassiadou A, Voutsinas G, Psiouri L, Leroy E, Polymeropoulos MH, Ilias A et al. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am J Hum Genet 1999; 65: 555-558. (Pubitemid 30463012)
3. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinsons disease. Nat Genet 1998; 18: 106-108.
4. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. Mutation in the alpha-synuclein gene identified in families with Parkinsons disease. Science 1997; 276: 2045-2047. (Pubitemid 27443610)
5. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55: 164-173. (Pubitemid 38166992)
6. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al. alpha- Synuclein locus triplication causes Parkinsons disease. Science 2003; 302: 841. (Pubitemid 37339619)
7. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinsons disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998; 57: 334-337. (Pubitemid 28182631)
8. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alphasynuclein in Lewy bodies. Nature 1997; 388: 839-840.
9. Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, Muzyczka N et al. Parkinsonlike neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci 2002; 22: 2780-2791. (Pubitemid 37465827)
10. Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinsons disease. Proc Natl Acad Sci USA 2002; 99: 10813-10818.
11. Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 2002; 8: 600-606. (Pubitemid 34633438)
12. Zhou W, Schaack J, Zawada WM, Freed CR. Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res 2002; 926: 42-50. (Pubitemid 34117588)
13. Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT et al. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis 2008; 29: 515-528.
14. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004; 117 (Part 10): 1875-1884. (Pubitemid 38745122)
15. Mackintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 2004; 381 (Part 2): 329-342.
16. Porter GW, Khuri FR, Fu H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 2006; 16: 193-202. (Pubitemid 43796125)
17. Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J et al. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 1999; 19: 5782-5791. (Pubitemid 29327915)
18. Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol 2002; 61: 245-253. (Pubitemid 34212599)
19. Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R, Ihara M. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice. Acta Neuropathol 2006; 112: 681-689. (Pubitemid 44615029)
20. Sato S, Chiba T, Sakata E, Kato K, Mizuno Y, Hattori N et al. 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J 2006; 25: 211-221. (Pubitemid 43077309)
21. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608. (Pubitemid 28207717)
22. McLean PJ, Kawamata H, Hyman BT. alpha-Synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 2001; 104: 901-912. (Pubitemid 32607439)
23. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinsons disease. Nat Neurosci 2000; 3: 1301-1306.
24. Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH et al. Intersecting pathways to neurodegeneration in Parkinsons disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 2006; 22: 404-420. (Pubitemid 44294281)
25. Masters SC, Fu H. 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem 2001; 276: 45193-45200.
26. Shin KJ, Wall EA, Zavzavadjian JR, Santat LA, Liu J, Hwang JI et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 2006; 103: 13759-13764. (Pubitemid 44413981)
27. Cao S, Gelwix CC, Caldwell KA, Caldwell GA. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci 2005; 25: 3801-3812. (Pubitemid 40570413)
28. Berg D, Riess O, Bornemann A. Specification of 14-3-3 proteins in Lewy bodies. Ann Neurol 2003; 54:135. (Pubitemid 36764993)
29. McFarland MA, Ellis CE, Markey SP, Nussbaum RL. Proteomics analysis identifies phosphorylation-dependent {alpha}-synuclein protein interactions. Mol Cell Proteomics 2008; 7: 2123-2137.
30. Chen XW, Sun SG, Cheng DB, Tian YY. Overexpression of 14-3-3 protein protects pheochromocytoma cells against 1-methyl-4-phenylpyridinium toxicity. Neurosci Bull 2006; 22: 281-287.
31. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97: 6049-6054. (Pubitemid 30367521)
32. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K. Inactivation of the 14-3-3 sigma gene is associated with 50 CpG island hypermethylation in human cancers. Cancer Res 2000; 60: 4353-4357. (Pubitemid 32103610)
33. Leffers H, Madsen P, Rasmussen HH, Honore B, Andersen AH, Walbum E et al. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J Mol Biol 1993; 231: 982-998. (Pubitemid 23209874)
34. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H et al. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 2003; 278: 2058-2065. (Pubitemid 36801450)
35. Morton DG, Shakes DC, Nugent S, Dichoso D, Wang W, Golden A et al. The Caenorhabditis elegans par-5 gene encodes a 14-3-3 protein required for cellular asymmetry in the early embryo. Dev Biol 2002; 241: 47-58. (Pubitemid 34066761)
36. Brunelli L, Cieslik KA, Alcorn JL, Vatta M, Baldini A. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta. Circ Res 2007; 100: e59-e71. (Pubitemid 46594890)
37. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK. Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 2006; 26: 1481-1487. (Pubitemid 44288972)
38. Wu JS, CheungWM, Tsai YS, Chen YT, FongWH, Tsai HD et al. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3epsilon upregulation. Circulation 2009; 119: 1124-1134.
39. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000; 287: 1265-1269. (Pubitemid 30112148)
40. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinsons models. Science 2006; 313: 324-328. (Pubitemid 44480951)